Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPMATINIB vs CARBOCYSTEINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPMATINIB vs CARBOCYSTEINE: Safety Overview

Metric CAPMATINIB CARBOCYSTEINE
Total FAERS Reports 2,301 699
Deaths Reported 583 129
Death Rate 25.3% 18.5%
Hospitalizations 388 407
Average Patient Age 71.9 yrs 59.3 yrs
% Female Patients 53.9% 58.7%
FDA Approval Date May 6, 2020 N/A
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route ORAL N/A
Marketing Status Prescription N/A